fda warning compounding semaglutide september 2025 issued 25 letters to telehealth companies for false and misleading claims about compounded GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Beyond the Headlines: FDA Warning

Systemic estradiol levels with low-dose vaginal estrogens

GLP-1 receptor agonists act wherever there are relevant receptors: in the pancreas, stomach, brain, kidneys, and blood vessels

Tryptophan extends the life of cytochrome p450

At Formation, our concierge dietitian creates personalized nutrition plans that support the biological processes BPC-157 is activating in your body

Our mission is to provide you with the tools and education needed to build a routine that actually yields results

Pennsylvania was among 16 states that covered GLP-1s for obesity treatment last year, according to KFFs Medicaid budget survey in October